Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Why Inovio Stock Is Crashing Today
10:59am, Friday, 23'rd Apr 2021
The biotech just lost funding for the late-stage study of its COVID-19 vaccine candidate.
Why Novavax, Inovio, and Protara Are Moving Today
09:54am, Friday, 23'rd Apr 2021
Novavax, Inc. (NASDAQ: NVAX), Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and Protara Therapeutics, Inc. (NASDAQ: TARA) are among the biotech movers Friday. Novavax Moves On Mid-stage Malaria Vaccine D
Inovio Dives After Government Backs Out of Covid Vaccine Deal
09:37am, Friday, 23'rd Apr 2021
The biotech said the decision was based on the wide availability of shots in the U.S., although the Phase 3 trial of the drug will go forward abroad.
Inovio stock plunges after U.S. government stops funding of Phase 3 trial of COVID-19 vaccine candidate
09:03am, Friday, 23'rd Apr 2021
Shares of Inovio Pharmaceuticals Inc. plunged 29.7% toward a 13-month low, enough to pace all premarket decliners Friday, after the company said the U.S. government has cut off funding for the Phase 3
Inovio Stock Slumps After Plans To Exclude US For COVID-19 Vaccine Candidate's Global Trial
08:45am, Friday, 23'rd Apr 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares dived in the premarket in reaction to the company's plans for a predominantly ex-U.S. Phase 3 trial for its COVID-19 vaccine candidate, INO-4800. Gi
INO Stock: Over 20% Decrease Pre-Market Explanation
08:24am, Friday, 23'rd Apr 2021
The stock price of Inovio Pharmaceuticals Inc (NASDAQ: INO) fell by over 20% pre-market. This is why it happened.
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800
08:00am, Friday, 23'rd Apr 2021
PLYMOUTH MEETING, Pa., April 23, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infec
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
06:00am, Wednesday, 21'st Apr 2021
It's all about the ultimate coronavirus vaccine.
INO Stock: Over 15% Increase Intraday Explanation
11:57am, Thursday, 15'th Apr 2021
The stock price of Inovio Pharmaceuticals Inc (NASDAQ: INO) increased by over 15% during intraday trading. This is why it happened.
INOVIO's COVID-19 Vaccine Candidate, INO-4800, Provides Broad Cross-reactive Immune Responses In Humans Against Variants of Concern
08:00am, Thursday, 15'th Apr 2021
PLYMOUTH MEETING, Pa., April 15, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people f
Do Options Traders Know Something About Inovio (INO) Stock We Don't?
09:51am, Monday, 12'th Apr 2021
Investors need to pay close attention to Inovio (INO) stock based on the movements in the options market lately.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its invest
This 1 Element May Be Holding Inovio's Vaccine Back
08:00am, Friday, 02'nd Apr 2021
It has to do with game-changing technology.
Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?
07:30am, Wednesday, 24'th Mar 2021
We believe that Inovio Pharmaceuticals , a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, is a good buying opportunity at the present time. INO s
Inovio VGX-3100 HPV Data Adds To Conviction
10:58pm, Tuesday, 23'rd Mar 2021
Inovio VGX-3100 HPV Data Adds To Conviction
